STTK compared with IMNM: revenue, margins and what each company keeps, and the suppliers and customers both name

STTKShattuck Labs, Inc.

Mkt capRevenueRevenue

IMNMImmunome Inc.

Mkt capRevenueRevenue

Compare

STTKShattuck Labs, Inc.

IMNMImmunome Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only STTK 4

—Kemwell Biopharma Privateunlistedsupplier

—ImmunoGenunlistedcustomer

—Kayak Therapeuticsunlistedcustomer

—Ono Pharmaceuticalunlistedcustomer

Shared 0

No shared counterparties.

Only IMNM 5

ABBVAbbVie Global Enterprisescustomer

BMYBristol-Myers Squibbsupplier

ZNTLZentalis Pharmaceuticalssupplier

—Ayala Pharmaceuticals

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlisted

supplier

1 more · IMNM chain ›

STTKShattuck Labs, Inc.

5.12▼−6.44%· post 5.12· delayed

Mkt cap$549.0MRevenue$1MQ3 FY25Revenue—

IMNMImmunome Inc.

20.31▲+0.01%· post 19.52· delayed

After hoursNov 4 '26delayed

Mkt cap$2.3BRevenue$4MQ2 FY25Revenue$9MFY24

Compare

After hoursNov 4 '26delayed

STTKShattuck Labs, Inc.

IMNMImmunome Inc.

5.12▼−6.44%post 5.12delayed

Price

20.31▲+0.01%post 19.52delayed

$549.0M

Mkt cap

$2.3B

Q3 FY25$1M

Revenue

$4MQ2 FY25

—

Revenue

$9MFY24

STTK5.12▼−6.44%vsIMNM20.31▲+0.01%After hoursNov 4 '26delayed